Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
Freight Technologies Announces Updates to its Board of Directors
CEO Javier Selgas, stated, “I am very pleased to welcome these two experienced directors to the Board, and am looking forward to working closely with them as the Company continues to focus on its next ...
Les Echos Patrimoine21h
Vision Marine Technologies Announces Approval of Stock Repurchase Program
Vision Marine Technologies Inc. approves a stock repurchase program, aiming to enhance shareholder value and demonstrate confidence in its vision for the future ...